News
LaVoieHealthScience Announces Building Company Narrative Workshop at 2023 BIO International Convention
…Preparing Companies for M&A, Partnering, and More BOSTON & NEW YORK, May 18, 2023–LaVoieHealthScience (LHS), an award-winning global health science investor relations and public relations...
Podcast: Donna LaVoie, President and CEO, joins PRSSA’s “PR with the Pros”
President and CEO Donna LaVoie was featured on the “PR with the Pros” podcast hosted by the Public Relations Student Society of America’s VP of Brand Engagement Nicole Steele. The show is designed...
LaVoieHealthScience Launches Strategic Communications Solutions for Emerging Health and Science Innovations
…New Practice Segment Addresses Current Market Conditions BOSTON, NEW YORK CITY, April 12, 2023 –LaVoieHealthScience (LHS) announced today the launch of its Emerging Health Convergence Practice...
LaVoieHealthScience Announces Appointment of Nick Hennen as Head of Media, Boston, Building Out Media Training for Staff and Clients
BOSTON & NEW YORK, Wednesday, November 9, 2022–LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
LaVoieHealthScience Announces Continuance of U.S. Service Marks for LHS Immersion® and The LHS Fifteen-Slide Presentation®
Proprietary Message & Positioning Platform Defines Narrative for Health & Science Innovators USPTO recognizes continued use of proprietary professional services, grants exclusive...
LaVoie Health Science Included in Fast 50 2021 – The fastest-growing private companies in Mass.
LaVoie Health Science was recently included in the Boston Business Journals Fast 50 2021 which is a list of the fastest-growing private companies in Mass. Read the article HERE.
Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience Interviewed by Global Business Reports
Donna LaVoie was recently interviewed by Global Business Reports. Read the interview HERE.
LaVoieHealthScience Names James (Jim) Heins as Senior Vice President and Managing Director of its New York Practice
LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of James (Jim) Heins as Senior Vice President and Managing Director of its New York practice, expanding the agency’s senior leadership team to seven members.
Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience, Named to PharmaVOICE 100
BOSTON AND NEW YORK - AUGUST 03, 2020 LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
LaVoieHealthScience Forms Strategic Alliance with Bioscience Valuation BSV GmbH
BOSTON/NEW YORK/GRAINAU, GERMANY – June 22, 2020 — LaVoieHealthScience (“LHS”) and Bioscience Valuation BSV GmbH (“BSV”) today announced a strategic alliance between the two firms. The alliance...